Cas 228401-24-9,Carbonic acid, 2-[2-amino-4-(1,1-dimethylethyl)phenoxy]ethyl 1,1-dimethylethyl ester

228401-24-9

Post Buying Request

Basic information

Product Name: Carbonic acid, 2-[2-amino-4-(1,1-dimethylethyl)phenoxy]ethyl 1,1-dimethylethyl ester
Synonyms:
CAS NO:228401-24-9
Molecular Formula: C17H27NO4
Molecular Weight: 309.406
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: Carbonic acid, 2-[2-amino-4-(1,1-dimethylethyl)phenoxy]ethyl 1,1-dimethylethyl ester(CAS DataBase Reference)
NIST Chemistry Reference: Carbonic acid, 2-[2-amino-4-(1,1-dimethylethyl)phenoxy]ethyl 1,1-dimethylethyl ester(228401-24-9)
EPA Substance Registry System: Carbonic acid, 2-[2-amino-4-(1,1-dimethylethyl)phenoxy]ethyl 1,1-dimethylethyl ester(228401-24-9)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 228401-24-9(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

228401-24-9 Suppliers

Recommended suppliers

228401-24-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 228401-24-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,2,8,4,0 and 1 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 228401-24:
(8*2)+(7*2)+(6*8)+(5*4)+(4*0)+(3*1)+(2*2)+(1*4)=109
109 % 10 = 9
So 228401-24-9 is a valid CAS Registry Number.

228401-24-9Upstream product

228401-23-8 5-tert-butyl-2-((2-tert-butoxycarbonyloxy)ethoxy)-1-nitrobenzene

228401-24-9Downstream Products

228401-24-9Relevant academic research and scientific papers

Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl Ureas

-

Page/Page column 13, (2008/12/04)

This invention relates to the use of a group of aryl ureas in treating raf mediated diseases, and pharmaceutical compositions for use in such therapy.

Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas

-

Page 21, (2010/02/08)

This invention relates to the use of a group of aryl ureas in treating raf mediated diseases, and pharmaceutical compositions for use in such therapy.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 228401-24-9